Stemtech (STEK) Net Margin (2021 - 2025)
Stemtech's (STEK) quarterly Net Margin came in at 323.57% in Q4 2025, down 29338.0% year-on-year from N/an in Q4 2024, and down 239.4% quarter-over-quarter from 95.34% in Q3 2025.
Stemtech (STEK) Net Margin (2021 - 2025) Analysis & Trends
Stemtech has disclosed Net Margin across 5 years of filings, most recently posting 323.57% for Q4 2025.
- Net Margin for Q4 2025 came in at 323.57%, down 29338.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 140.8% (down 6614.0% YoY), and the FY2025 annual result was 140.8%, down 6614.0% from the prior year.
- Net Margin came in at 323.57% for Q4 2025 at Stemtech, down from 95.34% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 1660.53% in Q3 2022 to a low of 1956.08% in Q2 2022.
- The 5-year median for Net Margin is 77.77% (2023), against an average of 125.34%.
- Peak annual rise in Net Margin reached 224649 bps in 2022, while the deepest fall reached 188065 bps in 2022.
- Stemtech's Net Margin stood at 64.62% in 2021, then gained by 22 bps to 50.18% in 2022, then slumped by 173 bps to 136.88% in 2023, then surged by 78 bps to 30.19% in 2024, then sank by 972 bps to 323.57% in 2025.
- The last three Net Margin figures came in at 323.57% (Q4 2025), 95.34% (Q3 2025), and 42.45% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Stemtech | - | - | 354,677.00 | -323.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -323.57% |
| Sep 30, 2025 | -95.34% |
| Jun 30, 2025 | -42.45% |
| Mar 31, 2025 | -168.05% |
| Dec 31, 2024 | -30.19% |
| Sep 30, 2024 | -113.55% |
| Jun 30, 2024 | -59.14% |
| Mar 31, 2024 | -102.75% |
| Dec 31, 2023 | -136.88% |
| Sep 30, 2023 | -80.11% |
| Jun 30, 2023 | -25.79% |
| Mar 31, 2023 | -197.38% |
| Dec 31, 2022 | -50.18% |
| Sep 30, 2022 | 1,660.53% |
| Jun 30, 2022 | -1,956.08% |
| Mar 31, 2022 | -44.05% |
| Dec 31, 2021 | -64.62% |
| Sep 30, 2021 | -585.96% |
| Jun 30, 2021 | -75.43% |
| Mar 31, 2021 | -15.88% |